Reata Pharmaceuticals Inc buy melinda
Start price
21.10.17
/
50%
?29.52
Target price
06.12.17
€31.57
Performance (%)
-30.35%
End price
06.12.17
€20.56
Summary
This prediction ended on 06.12.17 with a price of €20.56. Massive losses of -30.35% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reata Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 1.301% | -1.386% | 12.259% | 59.752% |
| iShares Nasdaq 100 | 0.612% | -4.172% | 1.687% | 86.147% |
| iShares Nikkei 225® | 8.772% | 9.777% | 30.041% | 63.047% |
| iShares S&P 500 | 0.254% | -2.301% | 0.794% | 57.981% |
Comments by melinda for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
PHARMA
Reata Pharmaceuticals, Inc.
Reata kündigt Ende der Präsentation der wichtigsten Ergebnisse der Phase - 2 - Studie KARDINAL während der 2017 Jahrestagung der American Society of Nephrology
(Vom Mitglied beendet)
Stopped prediction by melinda for Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?84.56
03.04.19
03.04.19
€92.00
04.11.19
04.11.19
0.00%
04.11.19
04.11.19
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?88.32
27.02.19
27.02.19
€90.20
04.03.19
04.03.19
2.32%
04.03.19
04.03.19
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?59.89
23.07.18
23.07.18
€63.14
25.07.18
25.07.18
12.39%
25.07.18
25.07.18
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?32.73
21.10.17
21.10.17
€35.00
06.12.17
06.12.17
-30.35%
06.12.17
06.12.17